Twice-yearly injections of the capsid inhibitor drug lenacapavir can prevent the vast majority of HIV infections, according to a Phase 3 clinical trial published Wednesday in the New England Journal of Medicine.
HIV pre-exposure prophylaxis (PrEP) has emerged as a crucial tool for fighting the global HIV epidemic, but researchers say daily pill regimens remain an obstacle to treatment adherence. “Long acting antiretrovirals have raised the bar with respect to the reach, efficacy and effectiveness that can be achieved in our efforts to prevent HIV,” said Onyema Ogbuagu, MBBCh, associate professor of medicine and pharmacology at Yale School of Medicine and director of the Yale Antivirals and Vaccines Research Program, who was the senior author of the study.
The trial enrolled 3,271 cisgender men and gender-diverse people and compared HIV twice-yearly lenacapavir injection to background infection rates and to Truvada, a daily pill for PrEP. Researchers say among 2,179 participants in the lenacapavir group, they found only two incident HIV infections – a 96% reduction compared to background HIV incidence. The Truvada group had nine incident cases among 1,086 participants. No new or significant safety concerns were identified.
The trial found lenacapavir decreased HIV incidence by 89% compared to Truvada. “Our study showed that twice-yearly injectable lenacapavir, beyond protecting 99.9% of recipients from acquiring HIV, superiorly outperformed a standard of care oral comparator, was safe and well tolerated,” Ogbuagu said.
Researchers say the nine participants in the Truvada group who experienced incident HIV infection showed evidence of low or no treatment adherence, underscoring the importance of PrEP options that fit a variety of patients and lifestyles. “With these results, we now have a new, potent and proven tool that can allow us expand and strengthen efforts to end HIV transmission globally,” Ogbuagu added.
About Yale School of Medicine
Yale School of Medicine educates leaders in medicine and science, fostering curiosity and critical inquiry in a diverse, inclusive environment. It is a global leader in biomedical research, clinical care, and medical education, ranking fourth in NIH funding and tenth in NIH dollars per faculty member. With over 1,700 physicians, Yale provides compassionate care to patients worldwide. The Yale System of Medical Education emphasizes critical thinking and independent research, producing leaders in academic medicine.
News
The Unresolved Puzzle of Long COVID: 30% of Young People Still Suffer After Two Years
A UCL study found that 70% of young people with long Covid recovered within 24 months, but recovery was less likely among older teenagers, females, and those from deprived backgrounds. Researchers emphasized the need [...]
Needle-Free: New Nano-Vaccine Effective Against All COVID-19 Variants
A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution against COVID-19, targeting all key variants effectively. Professor Ronit Satchi-Fainaro’s lab at Tel Aviv University’s Faculty of Medical and [...]
Photoacoustic PDA-ICG Nanoprobe for Detecting Senescent Cells in Cancer
A study in Scientific Reports evaluated a photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detecting senescent cells. Senescent cells play a role in tumor progression and therapeutic resistance, with potential adverse effects such as inflammation and tissue [...]
How Dysregulated Cell Signaling Causes Disease
Cell signaling is crucial for cells to communicate and function correctly. Disruptions in these pathways, caused by genetic mutations or environmental factors, can lead to uncontrolled cell growth, improper immune responses, or errors in [...]
Scientists Develop Super-Strong, Eco-Friendly Plastic That Bacteria Can Eat
Researchers at the Weizmann Institute have developed a biodegradable composite material that could play a significant role in addressing the global plastic waste crisis. Billions of tons of plastic waste clutter our planet. Most [...]
Building a “Google Maps” for Biology: Human Cell Atlas Revolutionizes Medicine
New research from the Human Cell Atlas offers insights into cell development, disease mechanisms, and genetic influences, enhancing our understanding of human biology and health. The Human Cell Atlas (HCA) consortium has made significant [...]
Bioeconomic Potential: Scientists Just Found 140 Reasons to Love Spider Venom
Researchers at the LOEWE Centre for Translational Biodiversity Genomics (TBG) have discovered a significant diversity of enzymes in spider venom, previously overshadowed by the focus on neurotoxins. These enzymes, found across 140 different families, [...]
Quantum Algorithms and the Future of Precision Medicine
Precision medicine is reshaping healthcare by tailoring treatments to individual patients based on their unique genetic, environmental, and lifestyle factors. At the forefront of this revolution, the integration of quantum computing and machine learning [...]
Scientists Have Discovered a Simple Supplement That Causes Prostate Cancer Cells To Self-Destruct
Menadione, a vitamin K precursor, shows promise in slowing prostate cancer in mice by disrupting cancer cell survival processes, with potential applications for human treatment and myotubular myopathy therapy. Prostate cancer is a quiet [...]
Scientists reveal structural link for initiation of protein synthesis in bacteria
Within a cell, DNA carries the genetic code for building proteins. To build proteins, the cell makes a copy of DNA, called mRNA. Then, another molecule called a ribosome reads the mRNA, translating it [...]
Vaping Isn’t Safe: Scientists Uncover Alarming Vascular Risks
Smoking and vaping impair vascular function, even without nicotine, with the most significant effects seen in nicotine-containing e-cigarettes. Researchers recommend avoiding both for better health. Researchers have discovered immediate impacts of cigarette and e-cigarette [...]
Twice-Yearly Lenacapavir for PrEP Reduces HIV Infections by 96%
Twice-yearly injections of the capsid inhibitor drug lenacapavir can prevent the vast majority of HIV infections, according to a Phase 3 clinical trial published Wednesday in the New England Journal of Medicine. HIV pre-exposure [...]
Did Social Distancing Begin 6,000 Years Ago? Neolithic Villagers May Have Invented It
Social distancing may have roots 6,000 years ago, as research shows Neolithic villages like Nebelivka used clustered layouts to control disease spread. The phrase “social distancing” became widely recognized in recent years as people [...]
Decoding Alzheimer’s: The Arctic Mutation’s Role in Unusual Brain Structures
Researchers have uncovered how certain genetic mutations lead to unique spherical amyloid plaques in inherited forms of Alzheimer’s, offering insights that could advance our understanding of the disease and improve therapeutic strategies. An international collaboration [...]
How Your “Lizard Brain” Fuels Overthinking and Social Anxiety
New research by Northwestern Medicine reveals how humans have evolved advanced brain regions to interpret others’ thoughts, connecting these areas with the amygdala, a part of the brain involved in emotional processing. Study sought [...]
How Did Life Begin? Researchers Discover Game-Changing Clue
New research offers a potential explanation for the formation of early Earth protocells. Few questions have captivated humankind more than the mystery of life’s origins on Earth. How did the first living cells emerge? [...]
